Severe Ileocolonic Crohnʼs Disease Flare Associated with Fecal Microbiota Transplantation Requiring Diverting Ileostomy
Author(s) -
Vivy Tran,
Jennifer Phan,
Benjamin Nulsen,
Lizhou Huang,
Marc Kaneshiro,
Guy A. Weiss,
Wendy Ho,
Jonathan Sack,
Christina Ha,
Daniel Z. Uslan,
Jenny Sauk
Publication year - 2018
Publication title -
acg case reports journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 4
ISSN - 2326-3253
DOI - 10.14309/crj.2018.97
Subject(s) - medicine , crohn's disease , inflammatory bowel disease , clostridium difficile , fecal bacteriotherapy , disease , ileostomy , transplantation , flare , refractory (planetary science) , fecal incontinence , gastroenterology , antibiotics , physics , astrobiology , astrophysics , microbiology and biotechnology , biology
Patients with inflammatory bowel disease (IBD) are at increased risk of developing infection (CDI). Fecal microbiota transplantation (FMT) is an effective therapy with a high success rate in preventing recurrent CDI. However, patients with IBD have decreased response to FMT for recurrent CDI, with several reports also suggesting potential IBD flare post-FMT. We present a case of mild ileocolonic Crohn's disease in a patient treated with FMT for recurrent CDI who subsequently developed severe steroid-refractory flare requiring surgical intervention 1 week post-FMT. Greater understanding of risk factors associated with post-FMT IBD flare is indicated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom